Abstract
Background
Sentinel node (SN) mapping based on the SN concept has been applied to early gastric cancer. However, it is still controversial whether or not the oncological safety is ensured in case pathological stage was advanced in these patients. The aim of this study was to investigate the validity of SN mapping in patients with clinically early staged gastric cancer diagnosed with pT2/deeper tumors.
Methods
We retrospectively analyzed 40 patients with a diagnosis of cT1N0 or cT2N0 single-lesion gastric cancer who were shown to have pT2 or deeper tumors after gastrectomy with SN mapping. We adopted a dual-tracer method using a radioactive colloid and blue dye to detect SNs. The diagnostic accuracy and distribution of SNs at each tumor site were analyzed.
Results
Of the 40 patients, 24 (60%) were postoperatively diagnosed as pT2, and 16 (40%) as pT3 or T4. SNs were detected in all patients. The false negative rate was 9% (1/11), and in that patient, the non-SN metastasis was observed within the SN basin. Diagnostic accuracy was 98% (39/40). Overall distribution of SNs was similar to that for patients with early gastric cancer. No significant differences in overall and recurrence-free survival were observed between the patients who underwent standard gastrectomy and those who underwent function-preserving gastrectomy, based on the results of SN mapping.
Conclusions
Our results confirmed validity of SN mapping for patients with clinically early staged gastric cancer diagnosed with pT2/deeper tumors after gastrectomy. Closed surveillance without additional surgical treatment is an option for these patients.
Similar content being viewed by others
Abbreviations
- p:
-
Pathological
- SN:
-
Sentinel node
- LN:
-
Lymph node
- OS:
-
Overall survival
- RFS:
-
Recurrence-free survival
References
Wong JHCL, Morton DL (1991) Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 214:637–641
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398
Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami M et al (2013) Sentinel node mapping for gastric cancer: A prospective multicenter trial in Japan. J Clin Oncol 31:3704–3710
Niihara M, Takeuchi H, Nakahara T, Saikawa Y, Takahashi T, Wada N et al (2016) Sentinel lymph node mapping for 385 gastric cancer patients. J Surg Res 200:73–81
Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A (2003) Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 90:178–182
Morita D, Tsuda H, Ichikura T, Kimura M, Aida S, Kosuda S et al (2007) Analysis of sentinel node involvement in gastric cancer. Clin Gastroenterol Hepatol 5:1046–1052
Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M (2002) Radio-guided sentinel node detection for gastric cancer. Br J Surg 89:604–608
Takeuchi M, Takeuchi H, Kawakubo H, Kitagawa Y (2018) Update on the indications and results of sentinel node mapping in upper GI cancer. Clin Exp Metastasis 35:455–461
Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ et al (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248:721–727
Seevaratnam R, Cardoso R, McGregor C, Lourenco L, Mahar A, Sutradhar R et al (2011) How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis Gastric Cancer 15:3–18
Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24:1–21
Sobin L, Gospodarowicz MWC (eds) (2009) TNM Classification of Malignant Tumours, 7th edn. Wiley-Liss, New York
Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112
Kinami S, Fujimura T, Ojima E, Fushida S, Ojima T, Funaki H et al (2008) PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow. Int J Clin Oncol 13:320–329
Mayanagi S, Takahashi N, Mitsumori N, Arigami T, Natsugoe S, Yaguchi Y et al (2020) Sentinel node mapping for post-endoscopic resection gastric cancer: multicenter retrospective cohort study in Japan. Gastric Cancer. https://doi.org/10.1007/s10120-019-01038-3
Takeuchi M, Takeuchi H, Kawakubo H, Shimada A, Nakahara T, Mayanagi S et al (2019) Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer: sentinel node concept. Gastric Cancer 22:223–230
Santos FA, Drummond-Lage AP, Rodrigues MA, Cabral AM, Pedrosa MS, Braga H et al (2016) Sentinel node biopsy using blue dye and technetium99 in advanced gastric cancer: anatomical drainage and clinical application. Braz J Med Biol Res. https://doi.org/10.1590/1414-431x20165341
Bara T, Gurzu S, Jung I, Borz C, Banias L, Bara T (2019) Sentinel node biospy using intravital blue dye. Medicine (Baltimore) 98:e14951
Yano K, Nimura H, Mitsumori N, Takahashi N, Kashiwagi H, Yanaga K (2012) The efficiency of micrometastasis by sentinel node navigation surgery using indocyanine green and infrared ray laparoscopy system for gastric cancer. Gastric Cancer 15:287–291
Yamashita K, Sakuramoto S, Nemoto M et al (2011) Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol 17:3390–3397
Haruta S, Shinohara H, Hosogi H, Ohkura Y, Kobayashi N, Mizuno A et al (2017) Proximal gastrectomy with exclusion of no. 3b lesser curvature lymph node dissection could be indicated for patients with advanced upper-third gastric cancer. Gastric Cancer 20:528–35
Sato Y, Katai H, Ito M, Otsuki S, Yamagata Y, Morita S (2018) Can proximal gastrectomy be justified for advanced adenocarcinoma of the esophagogastric junction? J Gastric Cancer 18:339–347
Takeuchi H, Oyama T, Kamiya S, Nakamura R, Takahashi T, Wada N et al (2011) Laparoscopy-assisted proximal gastrectomy with sentinel node mapping for early gastric cancer. World J Surg 35:2463–2471. https://doi.org/10.1007/s00268-011-1223-3
Ahn HS, Lee HJ, Yoo MW, Kim SG, Im JP, Kim SH et al (2009) Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer. J Surg Oncol 99:20–27
Acknowledgements
The authors thank Kumiko Motooka, who is a staff member at the Department of Surgery in the Keio University School of Medicine, for her help in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Kitagawa reports grants and personal fees from AsahiKASEI Co., Ltd., grants and personal fees from TAIHO PHARMACEUTICAL CO., LTD, grants and personal fees from CHUGAI PHARMACEUTICAL CO., LTD., grants from DAIICHI SANKYO COMPANY, LIMITED, grants from Merck Serono Co., Ltd., grants and personal fees from EA Pharma Co., Ltd., grants and personal fees from Yakult Honsha Co. Ltd., grants and personal fees from Otsuka Pharmaceutical Co., Ltd., grants from Takeda Pharmaceutical Co., Ltd., grants and personal fees from Otsuka Pharmaceutical Factory Inc., grants and personal fees from SHIONOGI & CO., LTD., grants from KAKEN PHARMACEUTICAL CO.,LTD., grants from Kowa Pharmaceutical Co., Ltd., grants and personal fees from Astellas Pharma Inc., grants from MEDICON INC., grants and personal fees from DAINIPPON SUMITOMO PHARMA Co., Ltd., grants and personal fees from Taisho Toyama Pharmaceutical Co., Ltd., grants from Kyouwa Hakkou Kirin Co., Ltd., grants from Pfizer Japan Inc., grants and personal fees from ONO PHARMACEUTICAL CO., LTD., grants and personal fees from NIHON PHARMACEUTICAL CO., LTD., grants from Japan Blood Products Organization, grants from Medtronic Japan Co., Ltd., grants and personal fees from Sanofi K.K., grants from Eisai Co., Ltd., grants from TSUMURA & CO., grants from KCI Licensing, Inc., grants from ABBOTT JAPAN CO., LTD., grants from FUJIFILM Toyama Chemical Co., Ltd., outside the submitted work;.
Ethical Approval
All procedures were followed in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and within the requirements of the 1964 Declaration of Helsinki and later versions. Informed consent or substitute for it was obtained from all patients included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Takeuchi, M., Kawakubo, H., Shimada, A. et al. The Results of Sentinel Node Mapping for Patients with Clinically Early Staged Gastric Cancer Diagnosed with pT2/deeper Tumors. World J Surg 45, 3350–3358 (2021). https://doi.org/10.1007/s00268-021-06254-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-021-06254-6